Cellbxhealth partners with AdventHealth on CTC‑based monitoring in two major cancer studies
18th May 2026 Uncategorised 0
Parsortix platform to support minimally invasive analysis across various cancer trials

More: Cellbxhealth partners with AdventHealth on CTC‑based monitoring in two major cancer studies
Source: News
